Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,142 ILa | -1.72% | -8.05% | +146.60% |
May. 01 | InterCure Ltd. Provides Revenue Guidance for the Full Year 2024 | CI |
May. 01 | InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+146.60% | 145M | |
-.--% | 339M | |
+27.57% | 251M | |
+12.37% | 232M | |
+44.19% | 188M | |
+34.59% | 122M | |
-28.57% | 121M | |
-42.37% | 118M | |
-3.85% | 83.74M | |
+150.00% | 75.33M |
- Stock Market
- Equities
- INCR Stock
- News InterCure Ltd.
- Novellusdx Ltd. announced that it has received $12.5 million in funding from Pontifax Ltd., InterCure Ltd., OrbiMed Advisors, L.L.C.